BioCryst Reports Fourth Quarter & Full Year 2015 Financial Results

Go back to BioCryst Reports Fourth Quarter & Full Year 2015 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.99 +0.04 (0.45%)
Previous Close $8.95    52 Week High $10.98 
Open $9.10    52 Week Low $1.63 
Day High $9.54    P/E N/A 
Day Low $8.98    EPS $-0.68 
Volume 8,882,729